Results from mixed-effect regression models for Stroop Blocks 1 and 2. by Nicholas P. Carruth (16469743)

BAG5 protected against MPP⁺- or rotenone-induced mitochondrial damage by up-regulating PINK1. by Xuejing Wang (514409)

“…Under MPP⁺ treatment, apoptosis of the stable cell line overexpressing Myc-BAG5 was significantly decreased compared with Myc stable cell line. …”

Demographic data underlying burned and unburned structures. by Erin Conlisk (163376)

Image 5_Using sodium glycodeoxycholate to develop a temporary infant-like gut barrier model, in vitro.pdf by Francesca Bietto (21511316)

“…</p>Methods<p>This study aimed to develop an in vitro model of the infant gut barrier treating Caco-2/HT29-MTX with 0.5, 0.8, and 1 mM sodium glycodeoxycholate (GDC).…”

Parameters of the TEG in IE patients and healthy volunteers at admission. by Ekaterina M. Koltsova (5464523)

Dynamics of thromboelastography parameters throughout the hospital stay. by Ekaterina M. Koltsova (5464523)

Image_5_Correlation of Longitudinal Gray Matter Volume Changes and Motor Recovery in Patients After Pontine Infarction.tif by Peipei Wang (580944)

“…At the end of sixth month after stroke onset, the GMV increase was found in the ipsilateral mediodorsal thalamus, superior frontal gyrus, and the contralateral precuneus. Across five times during a period of 6-month, a negative correlation was observed between mean GMV in the contralateral uvula, culmen, putamen, and ipsilateral tuber/tonsil and mean Fugl-Meyer (FM) score. …”

Kavain did not affect propofol potentiation, but modestly reduced propofol activation at α1β2γ2L GABA_ARs. by Han Chow Chua (817600)

Supplementary Material for: Severe Pulmonary Hypertension Associated with COPD: Hemodynamic Improvement with Specific Therapy by Girard A. (4154179)

“…After 6 ± 3 months, pulmonary vascular resistance decreased from 8.5 ± 3 to 6.6 ± 2 Wood units (p < 0.001), with significant improvement of cardiac index from 2.44 ± 0.43 to 2.68 ± 0.63 liters × min × m^-2 (p = 0.015) and mPAP from 48 ± 9 to 42 ± 10 mm Hg (p = 0.008). …”

<i>atoh1a</i> is required for the specification of the <i>lhx2b</i> neuronal population. by Ivan Belzunce (8394237)

“…Note that <i>atoh1b</i> expression (compare A-A’ and G-G’ with D-D’ and J-J’), and the lateral domains of <i>lhx2b</i> diminished (compare white asterisks in B-B’ with E-E’, and H-H’ with K-K’), whereas the more medial domain does not decrease so dramatically (compare white arrowheads in B-B’ with E-E’, and H-H’ with K-K’). …”

Physiological responses to MD stress among banana leaves. by Baolin Kan (12936933)

Limb phenotypes and lung histology of <i>Fgf10</i>-CRISPR F0 embryos at E16.5. by Munenori Habuta (9525357)

Table_5_Dynamic Transcriptomic Analysis of Breast Muscle Development From the Embryonic to Post-hatching Periods in Chickens.xlsx by Jie Liu (15128)

“…A total of 9,447 differentially expressed genes (DEGs) were filtered (Q < 0.01, fold change > 2). Time series expression profile clustering analysis identified five significantly different expression profiles that were divided into three clusters. …”

Dynamics of thrombodynamics parameters throughout the hospital stay. by Ekaterina M. Koltsova (5464523)

Parameters of the thrombodynamics in IE patients and healthy volunteers at admission. by Ekaterina M. Koltsova (5464523)

Dynamics of routine coagulation tests throughout the hospital stay. by Ekaterina M. Koltsova (5464523)

Effect of menthol on intracellular accumulation and efflux of EPI. by Katsuhito Nagai (11668793)

CLP results in long-lasting myeloid inflammation in the brain. by Benjamin H. Singer (358781)

“…The proportion of PMN and monocytes increase at 14 days in post-CLP mice, however, while decreasing in sham operated controls. By 50 days after CLP, the proportion of PMN and monocytes decreases nearly to baseline.…”

Coagulation parameters in patients receiving and not receiving antithrombotic (ATT) therapy at admission (with anticoagulants or antiplatelet agents). by Ekaterina M. Koltsova (5464523)

Coagulation parameters in patients receiving and not receiving ancoagulant (AK) therapy at admission. by Ekaterina M. Koltsova (5464523)